Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0287877 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Tom Cremer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Autoantigens, Endoplasmic Reticulum-Associated Degradation, Proinsulin, Proteolysis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Diabetes Fonds.
Abstract (Originalsprache)
Type 1 diabetes (T1D) is characterized by HLA class I-mediated presentation of autoantigens on the surface of pancreatic β-cells. Recognition of these autoantigens by CD8 + T cells results in the destruction of pancreatic β-cells and, consequently, insulin deficiency. Most epitopes presented at the surface of β-cells derive from the insulin precursor molecule proinsulin. The intracellular processing pathway(s) involved in the generation of these peptides are poorly defined. In this study, we show that a proinsulin B-chain antigen (PPI B5-14 ) originates from proinsulin molecules that are processed by ER-associated protein degradation (ERAD) and thus originate from ER-resident proteins. Furthermore, screening genes encoding for E2 ubiquitin conjugating enzymes, we identified UBE2G2 to be involved in proinsulin degradation and subsequent presentation of the PPI B10-18 autoantigen. These insights into the pathway involved in the generation of insulin-derived peptides emphasize the importance of proinsulin processing in the ER to T1D pathogenesis and identify novel targets for future T1D therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Functional Genomics, Center for Neurogenomics and Cognitive Research, VU University, Amsterdam, The Netherlands.
- Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
- Department of Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Tom Cremer, Michael L van de Weijer, Robert Jan Lebbink, Emmanuel J H J Wiertz
Förderung
- Diabetes Fonds
Zitieren
APA
Cremer, T., Hoelen, H., van de Weijer, M. L., Janssen, G. M., Costa, A. I., van Veelen, P. A., Lebbink, R. J., & Wiertz, E. J. H. J. (2024). Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2. PLOS ONE. https://doi.org/10.1371/journal.pone.0287877
Vancouver
Cremer T, Hoelen H, van de Weijer ML, Janssen GM, Costa AI, van Veelen PA, et al. Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2. PLOS ONE. 2024. doi:10.1371/journal.pone.0287877
BibTeX
@article{Cremer2024,
author = {Cremer, Tom and Hoelen, Hanneke and van de Weijer, Michael L and Janssen, George M and Costa, Ana I and van Veelen, Peter A and Lebbink, Robert Jan and Wiertz, Emmanuel J H J},
title = {Proinsulin degradation and presentation of a proinsulin B-chain autoantigen involves ER-associated protein degradation (ERAD)-enzyme UBE2G2},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0287877}
}
EUVIMED